Recombinant CEACAM5 (Arcitumomab Biosimilar) antibody
Quick Overview for Recombinant CEACAM5 (Arcitumomab Biosimilar) antibody (ABIN5668278)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Anti-carcinoembryonic antigen (CEA) [Arcitumomab], Human IgG1, kappa
-
Specificity
- Recognises human carcinoembryonic antigen.
-
Characteristics
-
Original Species of Ab: Mouse
Original Format of Ab: Fab'
-
Purification
- Protein A affinity purified
-
Purity
- > 98 % as determined by SDS-PAGE
-
Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
-
Immunogen
- Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- This antibody binds to carcinoembryonic antigen and was used in the diagnosis of mammary carcinomas.
-
Comment
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- CEACAM5 (Arcitumomab Biosimilar)
-
Background
- CEA
-
UniProt
- Q13984
Target
-